Alliances
(by JT Pharmaceutical Business)
| COMPANY | Product/Compound | Mechanism | ARRANGEMENT |
| Toray | REMITCH® (Narfurafine Hydrochloride) |
K-opioid Receptor Agonist | In-License |
| Gilead Sciences |
Elvitegravir | Integrase Inhibitor | Out-License |
| Novartis | Trametinib | MEK (MAPK/ERK Kinase) Inhibitor | Out-License |
| Akebia | Riona® (Ferric Citrate) |
Phosphate Binder Oral Iron Replacement(additional indication) |
In-License |
| ALK-Abello | Allergen Scratch Extract Positive Control (Torii) Histamine Dihydrochloride |
Histamine Receptor Antagonist | In-License |
| LEO Pharma |
JTE-052 (delgocitinib) | JAK Inhibitor | Out-License |
| JW Pharmaceutical |
JTZ-951 (enarodustat) | HIF-PH Inhibitor | Out-License |
| Rohto Pharmaceutical |
JTE-052 (delgocitinib) | JAK Inhibitor | Out-License |
| Shenzhen Salubris Pharmaceuticals |
JTZ-951 (enarodustat) | HIF-PH Inhibitor | Out-License |
| Dermavant Sciences GmbH |
Tapinarof | Therapeutic AhR Modulating Agent |
In-License |
| BioCryst Pharmaceuticals | ORLADEYO Capsules | Plasma kallikrein inhibitor | In-License |
| Nogra pharma | NAC-GED-0507 | Selective PPARγ modulator | In-License |
| Verrica | VP-102 | 0.7% cantharidin | In-License |